Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
Diseases » Rectal cancer » Stats
 

Statistics about Rectal cancer

Prevalence and incidence statistics for Rectal cancer:

See also prevalence and incidence page for Rectal cancer

Incidence (annual) of Rectal cancer: 40,570 new cases for rectum cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)

Incidence Rate: approx 1 in 6,704 or 0.01% or 40,569 people in USA [about data]

Incidence extrapolations for USA for Rectal cancer: 40,569 per year, 3,380 per month, 780 per week, 111 per day, 4 per hour, 0 per minute, 0 per second. Note: this extrapolation calculation uses the incidence statistic: 40,570 new cases for rectum cancer in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)

Incidence statistics about Rectal cancer:

The following statistics relate to the incidence of Rectal cancer:

Survival rate statistics for Rectal cancer:

The following are statistics from various sources about the survival rate for Rectal cancer:

  • 59.2% of people with colon and rectal cancer survive after 5 years in the US 1983-90 (SEER)
  • 62% of white people survive 5 years for rectal cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 53% of African American people survive 5 years for rectal cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 62% survive 5 years for rectal cancer in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 5-year survival rate for black people with colon and rectal cancer is 49.5% in the US 1983-90 (SEER)
  • 5-year survival rate for people with colon and rectal cancer is 59.2% in the US 1983-90 (SEER)
  • 5-year survival rate for white people with colon and rectal cancer is 60.1% in the US 1983-90 (SEER)
  • 1-year survival rate for men aged 15-99 with rectum cancer is 69% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-99 with rectum cancer is 40.3% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 15-39 with rectum cancer is 79% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-39 with rectum cancer is 51% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 40-49 with rectum cancer is 80% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 40-49 with rectum cancer is 46% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 50-59 with rectum cancer is 78% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 50-59 with rectum cancer is 45% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 60-69 with rectum cancer is 74% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 60-69 with rectum cancer is 43% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 70-79 with rectum cancer is 67% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 70-79 with rectum cancer is 40% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 80-99 with rectum cancer is 56% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 80-99 with rectum cancer is 33% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-99 with rectum cancer is 71.4% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-99 with rectum cancer is 44.8% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-39 with rectum cancer is 87% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-39 with rectum cancer is 56% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 40-49 with rectum cancer is 81% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 40-49 with rectum cancer is 53% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 50-59 with rectum cancer is 82% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 50-59 with rectum cancer is 52% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 60-69 with rectum cancer is 78% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 60-69 with rectum cancer is 49% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 70-79 with rectum cancer is 70% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 70-79 with rectum cancer is 44% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 80-99 with rectum cancer is 54% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 80-99 with rectum cancer is 33% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 7 months is the median survival for patients with advanced colorectal cancer at time of diagnosis (Cancer, Vol 2, No. 8: 2211-2219, American Cancer Society)
  • 16 months is the median survival for patients with advanced colorectal who are still alive two years after diagnosis (Cancer, Vol 2, No. 8: 2211-2219, American Cancer Society)
  • Nearly 6 years is the median survival for patients with advanced colorectal who are still alive five years after diagnosis (Cancer, Vol 2, No. 8: 2211-2219, American Cancer Society)
  • more about deaths...»

Life Expectancy & Years of Life Lost for Rectal cancer

Average life years lost for Rectal cancer: 13.4 years for colon/rectum cancer (SEER)1

Society statistics for Rectal cancer

Hospitalization statistics for Rectal cancer:

The following are statistics from various sources about hospitalizations and Rectal cancer:

  • 0.12% (15,719) of hospital consultant episodes were for malignant neoplasm of rectosigmoid junction in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 94% of hospital consultant episodes for malignant neoplasm of rectosigmoid junction required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 65% of hospital consultant episodes for malignant neoplasm of rectosigmoid junction were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 35% of hospital consultant episodes for malignant neoplasm of rectosigmoid junction were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 7% of hospital consultant episodes for malignant neoplasm of rectosigmoid junction required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 12.8 days was the mean length of stay in hospitals for malignant neoplasm of rectosigmoid junction in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 10 days was the median length of stay in hospitals for malignant neoplasm of rectosigmoid junction in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 65 was the mean age of patients hospitalised for malignant neoplasm of rectosigmoid junction in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 28% of hospital consultant episodes for malignant neoplasm of rectosigmoid junction occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 20% of hospital consultant episodes for malignant neoplasm of rectosigmoid junction occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • % of hospital consultant episodes for malignant neoplasm of rectosigmoid jun70ction were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.09% (47,458) of hospital bed days were for malignant neoplasm of rectosigmoid junction in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.39% (49,530) of hospital consultant episodes were for malignant neoplasm of rectum in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 94% of hospital consultant episodes for malignant neoplasm of rectum required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 65% of hospital consultant episodes for malignant neoplasm of rectum were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 35% of hospital consultant episodes for malignant neoplasm of rectum were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 7% of hospital consultant episodes for malignant neoplasm of rectum required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 12.2 days was the mean length of stay in hospitals for malignant neoplasm of rectum in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 9 days was the median length of stay in hospitals for malignant neoplasm of rectum in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 65 was the mean age of patients hospitalised for malignant neoplasm of rectum in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 30% of hospital consultant episodes for malignant neoplasm of rectum occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 23% of hospital consultant episodes for malignant neoplasm of rectum occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 65% of hospital consultant episodes for malignant neoplasm of rectum were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • % (175,563) of hospital bed days were for malignant neoplasm of rectum in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.37% (46,755) of hospital consultant episodes were for benign neoplasm of colon, rectum, anus and anal canal in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 95% of hospital consultant episodes for benign neoplasm of colon, rectum, anus and anal canal required hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 56% of hospital consultant episodes for benign neoplasm of colon, rectum, anus and anal canal were for men in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 44% of hospital consultant episodes for benign neoplasm of colon, rectum, anus and anal canal were for women in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 2% of hospital consultant episodes for benign neoplasm of colon, rectum, anus and anal canal required emergency hospital admission in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 6.2 days was the mean length of stay in hospitals for benign neoplasm of colon, rectum, anus and anal canal in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 2 days was the median length of stay in hospitals for benign neoplasm of colon, rectum, anus and anal canal in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 64 was the mean age of patients hospitalised for benign neoplasm of colon, rectum, anus and anal canal in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 34% of hospital consultant episodes for benign neoplasm of colon, rectum, anus and anal canal occurred in 15-59 year olds in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 25% of hospital consultant episodes for benign neoplasm of colon, rectum, anus and anal canal occurred in people over 75 in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 81% of hospital consultant episodes for benign neoplasm of colon, rectum, anus and anal canal were single day episodes in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)
  • 0.076% (39,731) of hospital bed days were for benign neoplasm of colon, rectum, anus and anal canal in England 2002-03 (Hospital Episode Statistics, Department of Health, England, 2002-03)

About statistics:

This page presents a variety of statistics about Rectal cancer. The term 'prevalence' of Rectal cancer usually refers to the estimated population of people who are managing Rectal cancer at any given time. The term 'incidence' of Rectal cancer refers to the annual diagnosis rate, or the number of new cases of Rectal cancer diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.



Footnotes: 1. SEER Cancer Statistics Review 1975-2000, National Cancer Institute (NCI)

 

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise